Does Aetna Cover Zepbound? What Aetna's Own 2026 Documents Say

Aetna does not publish one yes or no for every member. It publishes drug lists for named plans, policy bulletins written for prescribers, and a plain warning that many of its plans exclude weight loss medications altogether. This guide reads those documents as they stood on September 29, 2026, and quotes them word for word.

On the two Aetna exclusions lists dated July 2026 that this page reviews, Zepbound is an excluded drug and Wegovy is one of the listed alternatives. Whether that applies to you depends on which list your plan uses and on choices your employer made. Coverage depends on your specific plan and its formulary. Majesta Health does not bill insurance. This page does not predict what any plan will decide.

*What this guide covers:*

• Which Aetna drug lists exclude Zepbound in 2026, and what they list instead
• Where Wegovy and other GLP-1 medicines appear on the same lists
• What Aetna means when it says an excluded drug "may be covered"
• The prior authorization criteria in Aetna's public Zepbound policies
• How those policies treat obstructive sleep apnea
• Why an employer's Aetna plan can differ, and how to check your own plan

Aetna and Zepbound at a glance: what each document says

The two pharmacy policies are dated 2025 and sit in a 2025 folder on aetna.com. They are the latest versions this page could find on aetna.com on September 29, 2026. That is the result of a search, not proof that no newer version exists, so check the version your plan applies.

Does Aetna cover Zepbound in 2026?

On the Aetna lists read for this page, Zepbound is an excluded drug. It appears on both 2026 Formulary Exclusions Drug Lists dated July 2026, one for the Aetna Standard Plan and one for the Standard Control Plan. Each list sets excluded drugs, under "DRUG NAME(S)", beside "PREFERRED OPTION(S)", the drugs the plan lists in their place.

That is not the whole answer, for three reasons.

1. The lists leave a door open. Both say: "Formulary removals/drugs not included on the preferred options list may be covered by the plan when preferred options are not clinically appropriate."
2. Many Aetna plans exclude the whole category. Aetna's Clinical Policy Bulletin 0039, last reviewed 03/10/2026, says: "Many Aetna benefit plans specifically exclude coverage of weight reduction medications under the pharmacy benefit and/or under the health benefits plan."
3. The lists describe employer coverage. They end with this line: "Your prescription drug coverage is provided by your employer. Aetna performs administrative services, but does not offer, insure, or otherwise underwrite the benefit."

So the honest answer to whether Aetna covers Zepbound for weight loss is that the standard Aetna lists read here exclude it, some plans exclude every weight loss drug, and your own plan documents decide. Coverage depends on your specific plan and its formulary.

A formulary is the plan's drug list. HealthCare.gov defines it as "A list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits. Also called a drug list."

Which Aetna drug lists exclude Zepbound, and what do they list instead?

Both July 2026 exclusions lists carry the same row. Under "DRUG NAME(S)" it reads "ZEPBOUND", and under "PREFERRED OPTION(S)" it reads "liraglutide, orlistat, QSYMIA, WEGOVY".

The lists print names in two styles, and the key at the top explains them. Names in capitals, such as WEGOVY and QSYMIA, are "Brand-name medicine". Names in lowercase italics, such as liraglutide and orlistat, are "Generic medicine". The lists also say the alternatives are not presented as equal treatments: "The preferred options listed below are a broad representation of available treatment options and do not necessarily represent clinical equivalency."

The January 2026 Aetna Pharmacy Drug Guide for the Aetna Standard Plan shows an earlier version of the same row. There, Zepbound is listed with preferred options "orlistat, QSYMIA, SAXENDA, WEGOVY". The July 2026 list names liraglutide where the January guide named Saxenda. The guide itself warns: "The formulary is updated the first week of each month. The formulary is subject to change."

The exclusions lists also name the pharmacy benefits manager: "Pharmacy benefits are administered by an affiliated pharmacy benefits manager, CVS Caremark®."

Does Aetna cover Wegovy?

Wegovy appears on the covered side of the same documents. It is a preferred option in the Zepbound row of both July 2026 lists. The January 2026 Drug Guide lists it in the "ANTIOBESITY" section, next to orlistat, Qsymia and Saxenda.

Being listed is not the same as being approved for you. Aetna's Zepbound Exception policy 6981-A says: "Medications considered formulary or preferred on your plan may still require a clinical prior authorization review." And a plan that excludes weight reduction medications, as described in the next sections, can reach Wegovy too, since the Drug Guide files it under "ANTIOBESITY".

What about other GLP-1 medicines?

GLP-1 medicines used for type 2 diabetes sit in a different part of the same lists. On the July 2026 Aetna Standard Plan list, Bydureon BCise and Victoza are excluded, and each row lists "liraglutide, MOUNJARO, OZEMPIC, RYBELSUS, TRULICITY" as preferred options. For background on the drug class, see what a GLP-1 medication is.

What does it mean when Aetna says an excluded drug "may be covered"?

The full sentence on both exclusions lists is: "Formulary removals/drugs not included on the preferred options list may be covered by the plan when preferred options are not clinically appropriate. For more information, please sign in or register on Aetna.com."

Read closely, it sets a condition, not a promise. Coverage of an excluded drug is possible under that sentence only when the preferred options are not clinically appropriate for the person, and the plan decides whether that condition is met.

The Zepbound Exception policy 6981-A, dated July 01, 2025, shows how Aetna frames that decision for prescribers. Its plan design summary lists Wegovy as the "Primary Formulary Alternative", Mounjaro as the "Secondary Alternative" and Zepbound as the "Non-Formulary Agent". The policy says: "This document informs prescribers of the availability of the primary formulary alternative (Wegovy) and secondary alternative (tirzepatide [Brand Mounjaro])."

For the secondary alternative, the policy lists criteria that include this one: "The patient has experienced an inadequate treatment response, intolerance, or has a contraindication to Wegovy. [ACTION REQUIRED: Documentation is required for approval.]" In other words, the policy expects the prescriber to document why the primary alternative does not fit. Mounjaro and Zepbound contain the same active ingredient but carry different FDA-approved uses; see how the Zepbound and Mounjaro labels differ.

What are Aetna's prior authorization criteria for Zepbound?

HealthCare.gov defines prior authorization as "Approval from a health plan that may be required before you get a service or fill a prescription in order for the service or prescription to be covered by your plan."

Aetna's policy 6947-C, "Zepbound PA with Limit FE Compatible", dated July 01, 2025, sets the criteria for plans that use it. In the policy's own notes, "FE" means "Formulary Excluded". For reducing excess body weight or maintaining weight reduction, the policy asks for all of the following:

• A prior program: "The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy."
• A body mass index (BMI) threshold: a baseline BMI "greater than or equal to 30", or a baseline BMI "greater than or equal to 27" with "at least ONE weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia)".
• Documentation: the BMI and comorbidity lines each carry the note "[ACTION REQUIRED: Documentation is required for approval.]"

Renewal has its own section, "Continuation of Therapy". For weight reduction, renewal requires a period on treatment and a documented response since the start of treatment, measured as the policy defines it; the exact thresholds are in the document linked below. The policy also states a duration of approval for each use.

Two limits of the policy are worth knowing. It carries a quantity limit table, which this page does not reprint. And it says it does not apply to certain vials "that are covered under the LillyDirect manufacturer program"; the policy lists which ones.

The policy also describes itself narrowly. Aetna writes that its pharmacy policy bulletins "are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice." Meeting the criteria on paper is not a coverage decision.

Does Aetna treat Zepbound for sleep apnea differently from weight loss?

Yes, in the criteria. The Zepbound label lists two approved uses, and Aetna's policy 6947-C writes a separate set of criteria for each. Section 1 of the Zepbound label on DailyMed includes the use "to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity."

For sleep apnea, the policy asks for an established diagnosis "with an apnea-hypopnea index (AHI) of at least 15 events per hour on polysomnography (PSG) or home sleep apnea test (HSAT) with a technically adequate device", and a current BMI "greater than or equal to 30". The prior weight management program required for the weight reduction use does not appear in the sleep apnea criteria.

Renewal for sleep apnea asks that "The patient has achieved or maintained a positive response to treatment from baseline, evidenced by a decrease in OSA symptoms."

What the documents read for this page do not say is whether a plan's exclusion of weight reduction medications also reaches Zepbound when it is prescribed for sleep apnea. That question belongs to the plan, and the answer is in your plan documents.

Why can an employer's Aetna plan differ from these lists?

Because the plan design, not the Aetna name on the card, sets what is covered. Four lines from Aetna's own documents show how.

• The exclusions lists: "Your prescription drug coverage is provided by your employer. Aetna performs administrative services, but does not offer, insure, or otherwise underwrite the benefit."
• The Drug Guide, to members: "Your specific prescription benefit plan design may not cover certain medications, products or categories, regardless of their appearance in this document."
• The Drug Guide disclaimers: "Your plan may not cover certain drugs such as infertility, erectile dysfunction, weight loss and smoking cessation."
• The Drug Guide, on changes: "You may be responsible for the full cost of medications and products that are removed from coverage."

The Drug Guide also describes state rules in Louisiana, Texas, California and Connecticut for fully insured members who already receive a drug when a list changes. Those rules are written in the guide's disclaimers, and they do not apply to every plan.

The two Aetna pharmacy policies quoted here are titled for the "Aetna Non-Medicare Prescription Drug Plan". For Medicare, see whether Medicare covers Wegovy, Ozempic and other GLP-1 medicines.

How can you check your own Aetna plan?

The Drug Guide points members to three places: "Visit www.aetna.com/formulary for the most up-to-date information. For a summary of your coverage or benefits plan log in to your secure member site. Or call the toll-free number on your member ID card."

1. Find the plan name on your member ID card or plan documents, and match it to the drug list that carries that name.
2. Look up Zepbound and Wegovy on that list, and note the date printed on it.
3. Ask whether your plan excludes weight loss medications as a category.
4. Ask whether Zepbound for obstructive sleep apnea is handled differently under your plan.
5. Ask your prescriber which policy the plan applies, and what documentation it asks for.

Questions for the member services call:

• Is Zepbound on my plan's formulary, excluded, or covered only by exception?
• Does my plan exclude weight loss medications?
• Is prior authorization required, and which policy number applies?
• If my employer designs the benefit, where is that written?

For how health savings and flexible spending accounts treat these medicines, see HSA and FSA rules for GLP-1 weight loss medication. For whether a generic version of Zepbound exists, see is there a generic Zepbound. Related guides from this series cover UnitedHealthcare and Zepbound and Blue Cross Blue Shield and Zepbound.

A licensed physician decides whether any of these medicines is appropriate for you, and the answer can be none of them. Coverage is a separate question that your plan answers.

What the primary sources say

• Aetna, 2026 Formulary Exclusions Drug List, Aetna Standard Plan, July 2026 (accessed September 29, 2026): "ZEPBOUND" with preferred options "liraglutide, orlistat, QSYMIA, WEGOVY"; "Formulary removals/drugs not included on the preferred options list may be covered by the plan when preferred options are not clinically appropriate."; "Pharmacy benefits are administered by an affiliated pharmacy benefits manager, CVS Caremark®."; "Your prescription drug coverage is provided by your employer. Aetna performs administrative services, but does not offer, insure, or otherwise underwrite the benefit."
• Aetna, 2026 Formulary Exclusions Drug List, Standard Control Plan, July 2026 (accessed September 29, 2026): "ZEPBOUND" with preferred options "liraglutide, orlistat, QSYMIA, WEGOVY"; "The preferred options listed below are a broad representation of available treatment options and do not necessarily represent clinical equivalency."
• Aetna, 2026 Aetna Pharmacy Drug Guide, Aetna Standard Plan, January 2026 (accessed September 29, 2026): "The formulary is updated the first week of each month. The formulary is subject to change."; "Your specific prescription benefit plan design may not cover certain medications, products or categories, regardless of their appearance in this document."; "Your plan may not cover certain drugs such as infertility, erectile dysfunction, weight loss and smoking cessation."
• Aetna, Clinical Policy Bulletin 0039, Weight Reduction Programs and Devices, Last Review 03/10/2026 (accessed September 29, 2026): "Many Aetna benefit plans specifically exclude coverage of weight reduction medications under the pharmacy benefit and/or under the health benefits plan."; "Under these plans, claims for weight reduction medications and for physician supervision of weight reduction programs will be denied based on that exclusion."
• Aetna, Pharmacy Clinical Policy Bulletin, Zepbound Exception 6981-A, July 01, 2025 (accessed September 29, 2026): "This document informs prescribers of the availability of the primary formulary alternative (Wegovy) and secondary alternative (tirzepatide [Brand Mounjaro])."; "Medications considered formulary or preferred on your plan may still require a clinical prior authorization review."
• Aetna, Pharmacy Clinical Policy Bulletin, Zepbound PA with Limit FE Compatible 6947-C, July 01, 2025 (accessed September 29, 2026): "The patient has participated in a comprehensive weight management program that encourages behavioral modification, reduced-calorie diet, AND increased physical activity with continuing follow-up for at least 6 months prior to using drug therapy."; "apnea-hypopnea index (AHI) of at least 15 events per hour"; "constitute neither offers of coverage nor medical advice."
• Eli Lilly and Company via DailyMed, Zepbound (tirzepatide) prescribing information, set id 487cd7e7-434c-4925-99fa-aa80b1cc776b, updated August 28, 2026 (accessed September 29, 2026): "to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition"; "to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity"
• HealthCare.gov Glossary, Formulary and Prior authorization (accessed September 29, 2026): "A list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits."; "Approval from a health plan that may be required before you get a service or fill a prescription in order for the service or prescription to be covered by your plan."

Every source is listed with its address below.

This article is for informational purposes only and does not constitute medical advice or a statement of coverage. Aetna documents are quoted word for word as published on the dates shown and as read on September 29, 2026. Drug lists and policies change, so check your own plan documents before relying on any of them. This page is not written, reviewed or endorsed by Aetna, and brand names belong to their owners. Majesta Health does not bill insurance. Medication is prescribed only if a licensed physician determines it is appropriate.

Telehealth prescribing rules differ by state. Read the state-by-state guide.